The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phosphorylation of Thr 495 Regulates Ca 2+ /Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity
Abstract
Abstract —The activity of the endothelial nitric oxide synthase (eNOS) can be regulated independently of an increase in Ca 2+ by the phosphorylation of Ser 1177 but results only in a low nitric oxide (NO) output. In the present study, we assessed whether the agonist-induced (Ca 2+ -dependent, high-output) activation of eNOS is associated with changes in the phosphorylation of Thr 495 in the calmodulin (CaM)-binding domain. eNOS Thr 495 was constitutively phosphorylated in porcine aortic endothelial cells and was rapidly dephosphorylated after bradykinin stimulation. In the same cells, bradykinin enhanced the phosphorylation of Ser 1177 , which was maximal after 5 minutes, and abolished by the CaM-dependent kinase II (CaMKII) inhibitor KN-93. Bradykinin also enhanced the association of CaMKII with eNOS. Phosphorylation of Thr 495 was attenuated by the protein kinase C (PKC) inhibitor Ro 31-8220 and after PKC downregulation using phorbol 12-myristate 13-acetate. The agonist-induced dephosphorylation of Thr 495 was completely Ca 2+ -dependent and inhibited by the PP1 inhibitor calyculin A. Little CaM was bound to eNOS immunoprecipitated from unstimulated cells, but the agonist-induced dephosphorylation of Thr 495 enhanced the association of CaM. Mutation of Thr 495 to alanine increased CaM binding to eNOS in the absence of cell stimulation, whereas the corresponding Asp 495 mutant bound almost no CaM. Accordingly, NO production by the Ala 495 mutant was more sensitive to Ca 2+ /CaM than the aspartate mutant. These results suggest that the dual phosphorylation of Ser 1177 and Thr 495 determines the activity of eNOS in agonist-stimulated endothelial cells. Moreover, the dephosphorylation of Thr 495 by PP1 precedes the phosphorylation of Ser 1177 by CaMKII. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In resting endothelial cells, Thr495 is generally phosphorylated”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“The phosphorylation has been attributed to protein kinase C (PKC) (297, 646), and the residue is dephosphorylated by protein phosphatase 1 (PP1)”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“Phosphorylation of Thr495 is a negative regulator of CaM binding to eNOS (297, 407, 646).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C. J., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 839
Self-citationNishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S., Uematsu, M., Nerem, R. M., Alexander, R. W., & Murphy, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116092 · Cited by 735
García‐Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
Phosphorylation of Endothelial Nitric Oxide Synthase in Response to Fluid Shear Stress
Corson, M. A., James, N. L., Latta, S. E., Nerem, R. M., Berk, B. C., & Harrison, D. G. (1996) · Circulation Research · doi:10.1161/01.res.79.5.984 · Cited by 521
Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
Busse, R., & Mülsch, A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80902-u · Cited by 511
Self-citationMolecular cloning and characterization of human endothelial nitric oxide synthase
Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M. A., Sundell, C. L., Wilcox, J. N., Lamas, S., & Michel, T. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80697-f · Cited by 489
Research works printed but not linked: 5
- 10.1161/hyp.25.2.180 · DOI
- 10.1161/res.79.5.984 · DOI
- 10.1161/res.82.6.686 · DOI
- Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature. 1999;400:792]. Nature. 1999;399:597–601.
- 10.1161/res.78.5.750 · DOI
Cited by
Sorted by citations
Items 201–300 of 770
Khoo, N. K. H., Rudolph, V., Cole, M. P., Golin-Bisello, F., Schopfer, F. J., Woodcock, S. R., Batthyany, C., & Freeman, B. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.046 · Cited by 79
“Also, agonist-induced activation of eNOS is also regulated, in part, by the dephoshorylation of Thr497 [67,68] which coincides with phosphorylation at Ser1179 and increased NO production.”
BackgroundBalakumar, P., & Kathuria, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01938.x · Cited by 78
“Treatment with 15d-PGJ2 or ciglitazone for 24 h decreased HUVEC membrane NADPH-dependent superoxide anion Table 2 Regulation of eNOS action by multiple protein kinases and phosphatases Serial number Kinases and phosphatases eNOS phosphorylation site Status of eNOS References 1 PKB Ser1177 phosphorylation Activation Di…”
BackgroundInfluentialChurch, J. E., & Fulton, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505968200 · Cited by 78
Current concepts on the role of nitric oxide in portal hypertension
Hu, L. S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i11.1707 · Cited by 81
Age-Related Changes in Phosphorylation of Endothelial Nitric Oxide Synthase in the Rat Penis
Musicki, B., Kramer, M. F., Becker, R. E., & Burnett, A. L. “. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.20349.x · Cited by 77
Bellien, J., Thuillez, C., & Joannidès, R. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00610.x · Cited by 76
Hydrogen Peroxide Is an Endothelium-Derived Hyperpolarizing Factor in Animals and Humans
Matoba, T., & Shimokawa, H. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.1 · Cited by 78
Endothelial control of vasomotion and nitric oxide production
Harrison, D. G., & Cai, H. “. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00073-0 · Cited by 75
HYPERTENSION AND OXIDATIVE STRESS
Ward, N. C., & Croft, K. D. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04457.x · Cited by 74
Mount, P. F., Hill, R., Fraser, S. A., Levidiotis, V., Katsis, F., Kemp, B. E., & Power, D. A. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00458.2004 · Cited by 74
Self-citationEndothelial Dysfunction in Primary Aldosteronism
Chen, Z., Tsai, C., Pan, C., Chou, C., Liao, C., Hung, C., Wu, V., Lin, Y., & TAIPAI Study Group (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205214 · Cited by 74
The spectrin cytoskeleton integrates endothelial mechanoresponses
Mylvaganam, S., Plumb, J. D., Yusuf, B., Li, R., Lu, C.-Y., Robinson, L. A., Freeman, S. A., & Grinstein, S. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00953-5 · Cited by 70
Statin Treatment and 3′ Polyadenylation of eNOS mRNA
Kosmidou, I., Moore, J. P., Weber, M., & Searles, C. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.154492 · Cited by 74
Saura, M., Zaragoza, C., Cao, W., Bao, C., Rodrı́guez-Puyol, M., Rodrı́guez-Puyol, D., & Lowenstein, C. J. (2002) · Circulation Research · doi:10.1161/01.res.0000040397.23817.e5 · Cited by 72
Ellis, A., Pannirselvam, M., Anderson, T. J., & Triggle, C. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705549 · Cited by 72
“…of EDHF-type relaxations in these vessels (Fisslthaler et al., 1999), and although the enzyme that synthesizes this substance, CYP-2C, was also reported to generate significant amounts of ROS in response to bradykinin, these ROS do not appear to mediate vasorelaxation (Fleming et al., 2001).”
BackgroundHe, M., Huang, T.-S., Li, S., Hong, H.-C., Chen, Z. B., Martin, M., Zhou, X., Huang, H., Su, S., Zhang, J., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312301 · Cited by 70
Chen, W., Chen, C.-H., Hsu, M., Chang, R.-W., Wang, C., & Lee, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116192 · Cited by 70
Oliveira‐Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.08.004 · Cited by 72
Chen, F., Kumar, S., Yu, Y., Aggarwal, S., Groß, C., Wang, Y., Chakraborty, T., Verin, A. D., Catravas, J. D., Lucas, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099823 · Cited by 69
Role of NADPH Oxidases in the Control of Vascular Gene Expression
Brandes, R. P. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770380115 · Cited by 67
Divergence of Angiogenic and Vascular Permeability Signaling by VEGF
Spyridopoulos, I., Luedemann, C., Chen, D., Kearney, M., Chen, D., Murohara, T., Principe, N., Isner, J. M., & Losordo, D. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000020006.89055.11 · Cited by 68
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis
Xu, S., Liu, B., Yin, M., Королева, М. В., Mastrangelo, M. A., Ture, S. K., Morrell, C. N., Zhang, D. X., Fisher, E. A. A., & Jin, Z. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9376 · Cited by 68
“Because eNOS can be phosphorylated at Thr495 that inhibits eNOS activity [22, 23], we also assessed the effect of GSK1016790A on eNOS phosphorylation at Thr495.”
BackgroundResultKumar, G., Dey, S. K., & Kundu, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118377 · Cited by 71
Siragusa, M., Justo, A. F. O., Malacarne, P. F., Strano, A., Buch, A., Withers, B., Peters, K. G., & Fleming, I. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa213 · Cited by 67
Self-citationElmahdy, M., Abdelghany, T. M., Hemann, C. F., Ewees, M. G., Mahgoup, E. M., Eid, M. S., Shalaan, M. T., Alzarie, Y. A., & Zweier, J. L. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00657.2019 · Cited by 68
Eroğlu, E., Saravi, S. S. S., Sorrentino, A., Steinhorn, B. S., & Michel, T. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910942116 · Cited by 63
Musicki, B., Palese, M., Crone, J. K., & Burnett, A. L. “. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021113 · Cited by 65
Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke
Srivastava, K., Bath, P. M., & Bayraktutan, U. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9777-z · Cited by 66
“In addition to Akt, many other kinases like protein kinase A (PKA), adenosine monophosphate-activated protein kinase (AMPK) and protein kinase C (PKC) regulate eNOS activity by mediating phosphorylation of Ser and Thr residues at different sites (Fleming et al. 2001; Schneider et al. 2003).”
BackgroundMolecular Mechanisms Underlying Vascular Remodeling in Hypertension
Zeng, X., & Yang, Y. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2502072 · Cited by 70
Modulation of the l -arginine/nitric oxide signalling pathway in vascular endothelial cells
Wyatt, A. W., Steinert, J. R., & Mann, G. E. (2004) · Biochemical Society Symposia · doi:10.1042/bss0710143 · Cited by 63
What is new in endothelium-derived hyperpolarizing factors?
Campbell, W. B., & Gauthier, K. M. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00008 · Cited by 64
Agonist-Stimulated Endothelial Nitric Oxide Synthase Activation and Vascular Relaxation
Fulton, D. J., Ruan, L., Sood, S. G., Li, C., Zhang, Q., & Venema, R. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.162933 · Cited by 62
Brixius, K., Bloch, W., Pott, C., Napp, A., Krahwinkel, A., Ziskoven, C., Koriller, M., Mehlhorn, U., Hescheler, J., Fleischmann, B. K., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705983 · Cited by 63
“Akt/ PKB is an enzyme which has been shown to be responsible for the eNOSSer1177 phosphorylation (Dimmeler et al., 1999; Fleming et al., 2001).”
BackgroundLan, T.-H., Xu, Z., Wang, Z., Wu, Y., Wu, W.-K., & Tan, H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.001 · Cited by 62
Boo, Y. C., Kim, H. J., Song, H. W., Fulton, D. J., Sessa, W. C., & Jo, H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.024 · Cited by 62
Oubaha, M., & Gratton, J. (2009) · Blood · doi:10.1182/blood-2008-12-196584 · Cited by 62
Wang, J., Tokoro, T., Matsui, K., Higa, S., & Kitajima, I. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.003 · Cited by 62
C-Reactive Protein Triggers Cell Death in Ischemic Cells
Sheriff, A., Kayser, S., Brunner, P., & Vogt, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630430 · Cited by 67
“eNOS is activated by an increase in intracellular calcium, leading to vasodilatation (72, 73), which could explain the drop of blood pressure in vivo.”
BackgroundKamoun, W. S., Karaa, A., Kresge, N., Merkel, S. M., Korneszczuk, K., & Clemens, M. G. (2005) · Hepatology · doi:10.1002/hep.20940 · Cited by 61
iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle
Jones, R. J., Jourd’heuil, D., Salerno, J. C., Smith, S. M., & Singer, H. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01247.2006 · Cited by 60
“CaMKII has been reported to regulate both eNOS and nNOS activity (6, 32).”
BackgroundGhimire, K., Zarić, J., Alday-Parejo, B., Seebach, J., Bousquenaud, M., Stalin, J., Bieler, G., Schnittler, H., & Rüegg, C. (2019) · Cells · doi:10.3390/cells8050388 · Cited by 60
High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism
Chu, S., & Bohlen, H. G. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00006.2004 · Cited by 60
Sindler, A. L., Reyes, R., Chen, B., Ghosh, P., Gurovich, A. N., Kang, L. S., Cardounel, A. J., Delp, M. D., & Muller‐Delp, J. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00341.2012 · Cited by 58
l-Theanine promotes nitric oxide production in endothelial cells through eNOS phosphorylation
Siamwala, J. H., Dias, P. M., Majumder, S., Joshi, M. K., Sinkar, V. P., Banerjee, G., & Chatterjee, S. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.02.016 · Cited by 58
Daiber, A., Steven, S., Vujačić-Mirski, K., Kalinovic, S., Oelze, M. W., Lisa, F. D., & Münzel, T. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103405 · Cited by 59
Wang, X., Song, S., Xiao, H., Gao, P., Li, X.-J., & Si, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363031 · Cited by 58
Regulation of Endogenous Reactive Oxygen Species in Platelets Can Reverse Aggregation
Clutton, P., Miermont, A. M., & Freedman, J. E. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000105889.29687.cc · Cited by 58
Redox Balance in the Aging Microcirculation: New Friends, New Foes, and New Clinical Directions
Muller‐Delp, J. M., Gurovich, A. N., Christou, D. D., & Leeuwenburgh, C. (2011) · Microcirculation · doi:10.1111/j.1549-8719.2011.00139.x · Cited by 56
Evidence of cardiovascular protection by moderate alcohol: Role of nitric oxide
Abou‐Agag, L. H., Khoo, N. K. H., Binsack, R., White, C. R., Darley-Usmar, V. M., Grenett, H. E., Booyse, F. M., Digerness, S. B., Zhou, F., & Parks, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.007 · Cited by 57
“increase S NO formation without a concomitant increase in eNOS protein [16].”
BackgroundStriking crosstalk of ROCK signaling with endothelial function
Noma, K., Kihara, Y., & Higashi, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.03.005 · Cited by 57
Long, C., Cook, L. G., Hamilton, S. L., Wu, G., & Mitchell, B. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000257914.80918.72 · Cited by 57
Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells
Chen, Y., Medhora, M. M., Falck, J. R., Pritchard, K. A., & Jacobs, E. R. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2005 · Cited by 55
Kumar, S., Sud, N., Fonseca, F. V., Hou, Y., & Black, S. M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00290.2009 · Cited by 56
Promotion of nitric oxide production: mechanisms, strategies, and possibilities
Gonzalez, M., Clayton, S., Wauson, E., Christian, D., & Tran, Q. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1545044 · Cited by 62
Slater, S. C., Ramnath, R. D., Uttridge, K., Saleem, M. A., Cahill, P. A., Mathieson, P. W., Welsh, G. I., & Satchell, S. C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.020 · Cited by 55
Boeldt, D. S., Yi, F. X., & Bird, I. M. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0053 · Cited by 54
“…such as 1177 were stimulatory to activity, while phosphorylation of 495 was inhibitory to activity (Dimmeler et al. 1999, Haynes et al. 2000, Fleming et al. 2001), but several recent studies of these and other phosphorylation events on eNOS expressed in Cos-7 cells, and UAEC in particular,…”
Ladage, D., Brixius, K., Hoyer, H., Steingen, C., Wesseling, A., Malan, D., Bloch, W., & Schwinger, R. H. G. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04424.x · Cited by 55
Chen, G., Xu, R., Wang, Y., Wang, P., Zhao, G., Xu, X., Gruzdev, A., Zeldin, D. C., & Wang, D. W. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00591.2011 · Cited by 55
Aqueous Humor Outflow Physiology in NOS3 Knockout Mice
Lei, Y., Zhang, X., Song, M., Wu, J., & Sun, X. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16564 · Cited by 53
Dexamethasone Blocks Hypoxia-induced Endothelial Dysfunction in Organ-cultured Pulmonary Arteries
Murata, T., Hori, M., Sakamoto, K., Karaki, H., & Ozaki, H. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1311oc · Cited by 53
“1177 by serine/threonine kinase Akt (11, 12 ).”
BackgroundAndreozzi, F., Formoso, G., Prudente, S., Hribal, M. L., Pandolfi, A., Bellacchio, E., Silvestre, S. D., Trischitta, V., Consoli, A., & Sesti, G. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162883 · Cited by 53
Ghosh, S., Gupta, M. K., Xu, W., Mavrakis, D. A., Janocha, A. J., COMHAIR, S. A. A., Haque, M. M., Stuehr, D. J., Yu, J., POLGAR, P. R., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00092.2016 · Cited by 57
Evangelista, S., Garbin, U., Pasini, A. F., Stranieri, C., Boccioletti, V., & Cominacini, L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.12.008 · Cited by 56
Takeda, H., Komori, K., Nishikimi, N., Nimura, Y., Sokabe, M., & Naruse, K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.051 · Cited by 53
MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction By Targeting S100A1
Sen, A., Ren, S., Lerchenmüller, C., Sun, J., Weiss, N., Most, P., & Peppel, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078684 · Cited by 52
“MiR-138 mimic transfected ECs, the reduction of S100A1 greatly increased eNOS phosphorylation on Thr-495, a demonstrated eNOS inhibitory site [12] (Figure 8B).”
BackgroundRamírez‐Sánchez, I., Maya-Ramos, L., Ceballos, G. M., & Villarreal, F. J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2010 · Cited by 52
Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK
Mount, P. F., Lane, N., Venkatesan, S., Steinberg, G. R., Fraser, S. A., Kemp, B. E., & Power, D. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.003 · Cited by 52
Self-citationInsulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90
Fulton, D. J., Harris, M. B., Kemp, B. E., Venema, R. C., Marrero, M. B., & Stepp, D. W. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00280.2004 · Cited by 52
Self-citationChen, W., Xiao, H., Rizzo, A. N., Zhang, W., Mai, Y., & Ye, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105479 · Cited by 52
“Previous studies have demonstrated that Thr497 functions as a switch for eNOS binding with Ca, CaM complex [42].”
BackgroundFujita, M., Minamino, T., Asanuma, H., Sanada, S., Hirata, A., Wakeno, M., Myoishi, M., Okuda, H., Ogai, A., Okada, K.-I., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000171184.84077.80 · Cited by 51
Dose dependent effects of cadmium on tumor angiogenesis
Wei, T., Jia, J., Wada, Y., Kapron, C. M., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16572 · Cited by 51
Schäfer, A., Burkhardt, M., Vollkommer, T., Bauersachs, J. K., Münzel, T. F., Walter, U., & Smolenski, A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01523-x · Cited by 51
“The activation has been suggested to involve a dephosphorylation of eNOS at Thr and phosphorylation at Ser [27-29].”
BackgroundcAMP signal transduction induces eNOS activation by promoting PKB phosphorylation
Zhang, X.-P., & Hintze, T. H. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00614.2005 · Cited by 51
“Because PP1 preferentially dephosphorylates eNOS at Thr495 and calyculin A is a potent inhibitor for PP1 at the concentration 10 8 M (15, 25), therefore, a preventive effect of calyculin A on dephosphorylation of Thr495 on eNOS induced by forskolin is presumable, whereas the prevention of phosphorylation of Ser1177 on…”
BackgroundInfluentialMolecular aspects of preeclampsia
Mohaupt, M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.02.005 · Cited by 50
Yan, T., Li, Q., Zhang, X., Wei-kang, W., Sun, J., Li, L., Zhang, Q., & Tan, H. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05438.x · Cited by 50
“Evidence suggests that PKC signalling inhibits eNOS activity not only by phosphorylating Thr-495, but also by dephosphorylating Ser-1177 in endothelial cells.(25,29,31) It was reported that the phosphorylation of Ser-1177 occurred simultaneously with the dephosphorylation of Thr-495 to activate eNOS.”
BackgroundMehebik‐Mojaat, N., Jaubert, A., Sabourault, D., Giudicelli, Y., & Ribière, C. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00320.2004 · Cited by 50
Heat Shock Protein 90 in Endothelial Nitric Oxide Synthase Signaling
Balligand, J. (2002) · Circulation Research · doi:10.1161/01.res.0000018173.10175.ff · Cited by 50
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Long, C., Cook, L. G., Wu, G., & Mitchell, B. M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.144808 · Cited by 49
Sildenafil Reduces Insulin-Resistance in Human Endothelial Cells
Mammi, C., Pastore, D., Lombardo, M. F., Ferrelli, F., Caprio, M., Consoli, C., Tesauro, M., Gatta, L., Fini, M., Federici, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014542 · Cited by 49
“It is known that the association of Ca/calmodulin complex with eNOS increases eNOS Ser phosphorylation and decreases Thr dephosphorylation [34].”
BackgroundFißlthaler, B., Michaelis, U. R., Randriamboavonjy, V., Busse, R., & Fleming, I. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00492-0 · Cited by 49
Self-citationRole of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells
Li, C., Ruan, L., Sood, S. G., Papapetropoulos, A., Fulton, D. J., & Venema, R. C. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.07.001 · Cited by 48
“Thr-497 phosphorylation negatively regulates eNOS activity with dephosphorylation of this site being associated with increased eNOS activity (Fleming et al., 2001; Harris et al., 2001; Michell et al., 2001).”
BackgroundAldosterone Enhances Ligand-Stimulated Nitric Oxide Production in Endothelial Cells
Mutoh, A., Isshiki, M., & Fujita, T. (2008) · Hypertension Research · doi:10.1291/hypres.31.1811 · Cited by 47
“However, the exact mechanisms involved in eNOS activation by GPCRassociated ligands and [Ca]i remain unclear due to exceptions such as bradykinin (24), angiotensin II (25, 26) angiotensin-(1–7) (27), and thrombin (28).”
BackgroundBonini, M. G., Stadler, K., Silva, S. D. O., Corbett, J. T., Dore, M. M., Petranka, J. G., Fernandes, D. C., Tanaka, L. Y., Duma, D., Laurindo, F. R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708615105 · Cited by 47
Evaluation of Endothelial Cells Differentiated from Amniotic Fluid-Derived Stem Cells
Benavides, O. M., Petsche, J. J., Moise, K. J., Johnson, A. J., & Jacot, J. G. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0392 · Cited by 47
Leiva, A., Fuenzalida, B., Barros, E., Sobrevia, B., Salsoso, R., Sáez, T., Villalobos-Labra, R., Silva, L., Chiarello, D. I., Toledo, F., et al. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666160222115158 · Cited by 50
Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1
Józefczuk, E., Nosalski, R., Saju, B., Crespo, E., Szczepaniak, P., Guzik, T. J., & Siedliński, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13450 · Cited by 47
Posttranslational Modification of Constitutive Nitric Oxide Synthase in the Penis
Musicki, B., Ross, A. E., Champion, H. C., Burnett, A. L. “., & Bivalacqua, T. J. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006999 · Cited by 47
“Reciprocal dephosphorylation of Thr-495 and phosphorylation of Ser-1177 appears to be essential for eNOS activity (Fleming et al, 2001; Harris et al, 2001; Michell et al, 2001).”
BackgroundRegulation of Endothelial Nitric-oxide Synthase (NOS) S-Glutathionylation by Neuronal NOS
Idigo, W., Reilly, S. N., Zhang, Y. H., Zhang, Y. H., Jayaram, R., Carnicer, R., Crabtree, M. J., Balligand, J., & Casadei, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.412031 · Cited by 47
“Mechanism of eNOS Uncoupling in the Myocardium of nNOS / Mice—eNOS uncoupling may result from oxidation of the enzyme co-factor BH4 (17), decreased availability of L-arginine (26), and increased eNOS S-glutathionylation (20) or Thr-495 phosphorylation (27, 28).”
BackgroundThick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension
Gonzalez‐Vicente, A., Sáez, F., Monzon, C. M., Asirwatham, J., & Garvin, J. L. (2018) · Physiological Reviews · doi:10.1152/physrev.00055.2017 · Cited by 46
Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure
Suvorava, T., Metry, S., Pick, S., & Kojda, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115256 · Cited by 49
Peluso, A. A., Bertelsen, J. B., Andersen, K., Mortensen, T. P., Hansen, P., Sumners, C., Bäder, M., Santos, R. A. S., & Steckelings, U. M. (2018) · Clinical Science · doi:10.1042/cs20171598 · Cited by 45
The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis
Hua, Y., Zhang, J., Liu, Q., Su, J., Zhao, Y., Zheng, G., Yang, Z., Zhuo, D., Ma, C., & Fan, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831847 · Cited by 45
α‐Tocopherol and Endothelial Nitric Oxide Synthesis
Heller, R., Werner‐Felmayer, G., & Werner, E. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.007 · Cited by 45
Crossthwaite, A. J., Ciruela, A., Rayner, T. F., & Cooper, D. M. F. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.018275 · Cited by 47
“For instance, endothelial nitric-oxide synthase, which contains an -helical calmodulin binding domain similar to that present on the N terminus of AC8, contains a threonine residue, which, upon phosphorylation, prevents calmodulin binding (Fleming et al., 2001).”
BackgroundA High-Salt Diet Dissociates NO Synthase-3 Expression and NO Production by the Thick Ascending Limb
Herrera, M., Silva, G. A., & Garvin, J. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000196274.78603.85 · Cited by 45
Loot, A. E., & Fleming, I. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181ed088d · Cited by 44
Self-citationMost, P., Lerchenmüller, C., Rengo, G., Mahlmann, A., Ritterhoff, J., Rohde, D., Goodman, C. R., Busch, C. J., Laube, F., Heißenberg, J., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.275156 · Cited by 44
Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity
Murthy, S., Koval, O. M., Diaz, J. M. R., Kumar, S., Nuno, D. W., Scott, J. A., Allamargot, C., Zhu, L. J., Broadhurst, K., Santhana, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186311 · Cited by 43
Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., Cowart, L. A., Xiao, X., Wang, D. W., & Xia, Y. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.08.005 · Cited by 44
Metadata
- Authors
- Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation Research
- Published
- 2001-06-08
- Volume
- 88
- Issue
- 11
- Pages
- E68-75
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2135297555
- Cited by
- 770
- References
- 38
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 18 · 2017: 29 · 2016: 30 · 2015: 39 · 2014: 34 · 2013: 28 · 2012: 49
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft (SFB 553)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- endothelial nitric oxide synthase, calmodulin binding, CaMKII, PP1 phosphatase, calyculin A, bradykinin, protein kinase C, nitric oxide production, endothelial cells, dual phosphorylation, calmodulin-dependent kinase II, calmodulin
- MeSH terms
- Animals, Binding Sites, Bradykinin, Calcium, Calmodulin, Cells, Cultured, Coronary Vessels, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Phosphorylation, Precipitin Tests, Protein Kinase C, Proto-Oncogene Proteins, Swine, Threonine, Blotting, Western, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Nitric Oxide Synthase, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Nitric Oxide Synthase Type III, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review